Aarkstore - Essential Thrombocythemia - Pipeline Review, H2 2014

1
Aarkstore - Essential Thrombocythemia - Pipeline
Review, H2 2014
www.aarkstore.com
2
Summary

• Essential Thrombocythemia - Pipeline Review, H2
  2014, provides an overview of
• the Essential Thrombocythemias therapeutic
  pipeline.
• This Market Research Report provides
  comprehensive information on the therapeutic
• development for Essential Thrombocythemia,
  complete with comparative analysis at various
• stages, therapeutics assessment by drug target,
  mechanism of action (MoA), route of
• administration (RoA) and molecule type, along
  with latest updates, and featured news and
• press releases. It also reviews key players
  involved in the therapeutic development for
• Essential Thrombocythemia and special features on
  late-stage and discontinued projects.

www.aarkstore.com
www.aarkstore.com
3
Scope

• - The report provides a snapshot of the
  global therapeutic landscape of Essential
  Thrombocythemia- The report reviews key pipeline
  products under drug profile section which
  includes, product description, MoA and RD brief,
  licensing and collaboration details other
  developmental activities - The report reviews
  key players involved in the therapeutics
  development for Essential Thrombocythemia and
  enlists all their major and minor projects- The
  report summarizes all the dormant and
  discontinued pipeline projects - A review of the
  Essential Thrombocythemia products under
  development by companies and universities/research
  institutes based on information derived from
  company and industry-specific sources- Pipeline
  products coverage based on various stages of
  development ranging from pre-registration till
  discovery and undisclosed stages- A detailed
  assessment of monotherapy and combination therapy
  pipeline projects- Coverage of the Essential
  Thrombocythemia pipeline on the basis of target,
  MoA, route of administration and molecule type-
  Latest news and deals relating related to
  pipeline products

www.aarkstore.com
www.aarkstore.com
4
Reasons to buy

• - Provides strategically significant
  competitor information, analysis, and insights to
  formulate effective RD development strategies-
  Identify emerging players with potentially strong
  product portfolio and create effective
  counter-strategies to gain competitive
  advantage- Develop strategic initiatives by
  understanding the focus areas of leading
  companies- Identify and understand important and
  diverse types of therapeutics under development
  for Essential Thrombocythemia- Plan mergers and
  acquisitions effectively by identifying key
  players of the most promising pipeline- Devise
  corrective measures for pipeline projects by
  understanding Essential Thrombocythemia pipeline
  depth and focus of Indication therapeutics-
  Develop and design in-licensing and out-licensing
  strategies by identifying prospective partners
  with the most attractive projects to enhance and
  expand business potential and scope- Modify the
  therapeutic portfolio by identifying discontinued
  projects and understanding the factors that drove
  them from pipeline

www.aarkstore.com
www.aarkstore.com
5
Table of Contents

• Introduction Global Markets Direct Report
  Coverage Essential Thrombocythemia Overview
  Therapeutics Development Pipeline Products for
  Essential Thrombocythemia - Overview Pipeline
  Products for Essential Thrombocythemia -
  Comparative Analysis Essential Thrombocythemia -
  Therapeutics under Development by Companies
  Essential Thrombocythemia - Therapeutics under
  Investigation by Universities/Institutes
  Essential Thrombocythemia - Pipeline Products
  Glance Late Stage Products Clinical Stage
  Products Early Stage Products Essential
  Thrombocythemia - Products under Development by
  Companies Essential Thrombocythemia - Products
  under Investigation by Universities/Institutes
  Essential Thrombocythemia - Companies Involved
  in Therapeutics Development AstraZeneca PLC
  

www.aarkstore.com
www.aarkstore.com
6
List Of Tables

• Number of Products under Development for
  Essential Thrombocythemia, H2 2014 Number of
  Products under Development for Essential
  Thrombocythemia - Comparative Analysis, H2 2014
  Number of Products under Development by
  Companies, H2 2014 Number of Products under
  Investigation by Universities/Institutes, H2 2014
  1Comparative Analysis by Late Stage Development,
  H2 2014 Comparative Analysis by Clinical Stage
  Development, H2 2014 Comparative Analysis by
  Early Stage Development, H2 2014 Products under
  Development by Companies, H2 2014 Products under
  Investigation by Universities/Institutes, H2 2014
  Essential Thrombocythemia - Pipeline by
  AstraZeneca PLC, H2 2014

www.aarkstore.com
7
List Of Figures

• Number of Products under Development for
  Essential Thrombocythemia, H2 2014 Number of
  Products under Development for Essential
  Thrombocythemia - Comparative Analysis, H2 2014
  Number of Products under Development by
  Companies, H2 2014 Comparative Analysis by
  Clinical Stage Development, H2 2014 Assessment
  by Monotherapy Products, H2 2014 Number of
  Products by Top 10 Target, H2 2014 Number of
  Products by Stage and Top 10 Target, H2 2014
  Number of Products by Top 10 Mechanism of
  Action, H2 2014 Number of Products by Stage and
  Top 10 Mechanism of Action, H2 2014 Number of
  Products by Top 10 Route of Administration, H2
  2014

www.aarkstore.com
8
Related Market Research reports

• Blirt S.A. - Product Pipeline Review 2014
• Auris Medical Holding AG - Product Pipeline
  Review 2014
• Integral Molecular, Inc. - Product Pipeline
  Review 2014
• DaVinci Biosciences, LLC - Product Pipeline
  Review 2014
• Actavis plc - Product Pipeline Review - 2014

www.aarkstore.com
9
Related Market Research reports

• TiGenix NV - Product Pipeline Review 2014
• Egenix, Inc. - Product Pipeline Review 2014
• SkyePharma PLC - Product Pipeline Review 2014
• MediWound Ltd. - Product Pipeline Review 2014
• BioTech Tools s.a. - Product Pipeline Review -
  2014

www.aarkstore.com
10
Aarkstore - Essential Thrombocythemia - Pipeline
Review, H2 2014
Format Price
PDF 2000
Site Licence 4000
Enterprise Wide Licence  6000
www.aarkstore.com
11
Contact Us

• Office
• Office No. - 809, 8th Floor,
• B-Wing, Mahaavir Icon, 
• Plot No.- 89 90, Sector-15,
• CBD-Belapur, Navi Mumbai 400614, 
• Maharashtra, India.
• 24/7 Online Support 91 9987295242
• General Inquiries 91 - 22 2756 4953
• You Can Visit http//www.aarkstore.com
• OR Mail us at contact_at_aarkstore.com
• Blog http//www.aarkstore.com/blog/
• Conference http//conference.aarkstore.com/
• News http//www.aarkstore.com/news

www.aarkstore.com